CAMP4 Therapeutics Corpor... (CAMP)
NASDAQ: CAMP
· Real-Time Price · USD
3.03
0.05 (1.68%)
At close: Oct 03, 2025, 3:59 PM
3.00
-0.99%
After-hours: Oct 03, 2025, 07:51 PM EDT
CAMP4 Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
March - February.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
Net Income | -12.59M | -12.43M | -13.28M | -13.48M | -12.58M | -12.45M | -12.99M | -11.7M | -4.03M | -8.09M | -4.73M | -7.49M | -12.17M | -9.18M | -10.54M | -5.42M | -6M | 26.42M |
Depreciation & Amortization | 430K | 421K | 418K | 418K | 424K | 436K | 435K | 430K | 5.55M | 5.66M | 5.22M | 5.39M | 5.5M | 5.72M | 5.97M | 5.64M | 5.48M | 1.4M |
Stock-Based Compensation | 1M | 861K | 797K | 1.59M | 786K | 856K | 636K | 722K | 2.18M | 2.02M | 2.03M | 3.2M | 2.96M | 2.76M | 3.15M | 2.94M | 2.47M | 1.86M |
Other Working Capital | 618K | -3.9M | 1.15M | 229K | -1.48M | -1.4M | -162K | 3.13M | -1.34M | 972K | 210K | -431K | -2.66M | -3.68M | -3.89M | -3.84M | -2.81M | -3.88M |
Other Non-Cash Items | 384K | 586K | 479K | 468K | 412.5K | 430K | 448K | 403K | 709K | 531K | 688K | 346K | 413K | 3.12M | 2.55M | 2.27M | 2.21M | -2.37M |
Deferred Income Tax | n/a | n/a | -480K | n/a | n/a | n/a | n/a | n/a | -304K | 544K | 3K | 20K | 109K | 76K | 139K | 87K | 163K | -373K |
Change in Working Capital | 428K | -3.72M | 297K | 1.31M | -2.53M | -413K | -312K | 3.59M | -7.08M | -1.76M | 630K | -11.58M | -12.36M | -10.02M | -8.41M | 4.87M | -3.85M | 3.24M |
Operating Cash Flow | -10.34M | -14.29M | -15.27M | -9.69M | -13.44M | -11.14M | -11.78M | -6.55M | -2.98M | -1.09M | 3.83M | -10.13M | -15.55M | -7.53M | -7.14M | 10.37M | 78K | 4.24M |
Capital Expenditures | n/a | -279K | -263K | n/a | -163K | -15K | -243K | -207K | -1.96M | -1.81M | -4.4M | -1.26M | -3.63M | -2.96M | -3.77M | -3.48M | -3.09M | -266K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -279K | -263K | n/a | -163K | -15K | -243K | -207K | -1.96M | -1.81M | -4.4M | -1.26M | -3.63M | -2.96M | -4.67M | -3.48M | 3.52M | -2.6M |
Debt Repayment | -43K | -36K | -96K | -90K | -89K | -89K | -121K | -89K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 115K | -115K | -3.16M | -327K | -723K | -115K | 58K | -115K | -257K | -190K | -107K | -1.14M | -425K | -45K | -111K | -2.96M | -1.06M | -71K |
Financial Cash Flow | 72K | -151K | 73.06M | -386K | -812K | -202K | -63K | -203K | -257K | 264K | -107K | -641K | -425K | 585K | -111K | -2.3M | -813K | 987K |
Net Cash Flow | -10.27M | -14.72M | 61.51M | -10.08M | -14.41M | -11.36M | -12.09M | -6.96M | -6.97M | -2.98M | -2.81M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Free Cash Flow | -10.34M | -14.56M | -11.55M | -9.69M | -13.6M | -11.16M | -12.03M | -6.76M | -4.94M | -2.9M | -569K | -11.39M | -19.18M | -10.49M | -10.91M | 6.9M | -3.02M | 3.98M |